Date published: 2025-10-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

1110012L19Rik Inhibitors

Chemical inhibitors of 1110012L19Rik can exert their effects through various cellular signaling pathways that are crucial for the protein's function. Staurosporine serves as a potent protein kinase inhibitor, and its broad activity spectrum includes kinases that may be involved in the same pathways as 1110012L19Rik, leading to a reduction in its activity. Similarly, Bisindolylmaleimide I targets protein kinase C, a kinase that could be an upstream regulator of 1110012L19Rik, resulting in diminished protein function upon inhibition. LY294002 and Wortmannin are both inhibitors of PI3K, a pivotal component of the PI3K/AKT pathway, which, when inhibited, reduces AKT phosphorylation and activity. This action can interfere with the regulation of 1110012L19Rik if it is governed by this pathway. Rapamycin targets mTOR by forming a complex with FKBP12, which can downregulate downstream signaling processes that might be responsible for regulating 1110012L19Rik's activity.

In this context, U0126 and PD98059, which selectively inhibit MEK1/2, prevent the activation of the MAPK/ERK pathway. This could lead to a decrease in 1110012L19Rik activity if it is regulated by ERK signaling. Similarly, SB203580 and SP600125 inhibit p38 MAP kinase and JNK, respectively; both of these inhibitors can suppress the function of 1110012L19Rik by interfering with their respective signaling pathways, assuming 1110012L19Rik is a downstream target. Dasatinib and PP2, as inhibitors of Src family kinases and BCR-ABL, could lead to inhibition of 1110012L19Rik if it is activated by signaling cascades associated with these kinases. Lastly, Lapatinib inhibits both EGFR and HER2 tyrosine kinases, and the blockade of these kinases can lead to the inhibition of 1110012L19Rik if its activity is contingent upon the downstream signaling of EGFR or HER2. Each of these chemicals, through their specific action on various kinases and signaling pathways, can lead to a functional inhibition of 1110012L19Rik by disrupting the cellular processes it relies on for its activity.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Staurosporine inhibits a broad spectrum of protein kinases which may include kinases involved in the signaling pathways 1110012L19Rik participates in, leading to its functional inhibition.

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$103.00
$237.00
36
(1)

Bisindolylmaleimide I specifically inhibits protein kinase C, which could be upstream of 1110012L19Rik, resulting in decreased activation and subsequent inhibition of 1110012L19Rik function.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 inhibits PI3K, potentially reducing AKT phosphorylation and activity. As PI3K/AKT pathway can regulate numerous proteins, inhibition by LY294002 can lead to the functional inhibition of 1110012L19Rik if it is downstream of this pathway.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin binds to FKBP12 and inhibits mTOR, which is a central regulator of cell growth and may control the function of 1110012L19Rik through downstream signaling pathways, thereby inhibiting the protein's function.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126 inhibits MEK1/2, which are upstream of ERK in the MAPK pathway; inhibition of this pathway can lead to decreased ERK activation and could inhibit the function of 1110012L19Rik if it is regulated by this pathway.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD98059 selectively inhibits MEK, which prevents the activation of MAPK/ERK pathway; if 1110012L19Rik functions downstream of this pathway, its activity would be inhibited by this chemical.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580 is a p38 MAP kinase inhibitor, which would inhibit the p38 MAPK signaling pathway. The inhibition of this pathway can functionally inhibit 1110012L19Rik if it is a downstream effector.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 inhibits JNK, and by doing so, it can inhibit downstream signaling pathways that may involve 1110012L19Rik, leading to its functional inhibition.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

Dasatinib is a Src family kinase inhibitor and also inhibits BCR-ABL; it could inhibit 1110012L19Rik if the protein's function is regulated by Src kinase signaling pathways.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$92.00
$223.00
30
(1)

PP2 is a selective inhibitor of Src family tyrosine kinases. By inhibiting Src family kinases, PP2 can functionally inhibit 1110012L19Rik if it relies on Src signaling for its activity.